It was during his meeting with the Belgian Prime Minister, Alexander De Croo, that the President of the Republic discussed France’s strategy concerning the vaccination campaign against Covid-19.
First generation vaccines
It is in a common desire to act together on many subjects, in particular in the fight against the coronavirus epidemic, that Emmanuel Macron shared the first details of his vaccination campaign with Belgium. The first generation vaccines will, first and foremost, be intended for a population ” very targeted “, Early 2021. These vaccines are those” on which we have little perspective and whose conservation and logistical conditions are quite complex, -80 or -20 degrees at this stage, and which we will rather reserve for the most sensitive audiences », Declared the President. This first phase will take place ” as soon as possible after the approvals of the European health authorities, between the end of December and the beginning of January “. It will therefore be for the attention of vulnerable groups, such as the elderly living in nursing homes, people at risk of contracting Covid-19 and healthcare workers, particularly exposed to the virus. As since the start of the pandemic, the French government is following the recommendations of the HAS (Haute Autorité de Santé).
The second generation of vaccines
In a second step, a second wave of vaccination will begin, ” somewhere between April and June which will be larger and more general and which will move towards a strategy of vaccination of the greatest number », Underlined the Head of State, on December 1st. As he recalls, the anti-Covid vaccine will not be compulsory: ” It will not be a compulsory vaccination strategy but a strategy of conviction and transparency “. This second step requires several conditions, in particular the mobilization of doctors and pharmacists to inject the product and answers to logistical questions. Moreover, in order to avoid a ” counterproductive race “And with the aim of European cooperation,” the vaccination strategy will be determined at national level by each Member State “. Remember that the Pfizer / BioNtech and Moderna laboratories recently submitted an authorization request for their vaccine. The European Medicines Agency has announced that it will hold an extraordinary meeting ” later »December 29, to agree or not for the vaccine of the American / German duo and January 12 for that of Moderna.
